RSS   Newsletter   Contact   Advertise with us
Post Online Media

Antibe appoints Yung Wu to board

AntibeAntibe Therapeutics Inc., a commercial-stage pharmaceutical company, announces the appointment of Yung Wu to its board of directors.
Mr. Wu is Managing Director of private equity firm NFQ Ventures and is a seasoned entrepreneur with a track record of successfully building and growing several businesses throughout his career.

As a serial founder and CEO, he has personally built 7 companies and produced multiple successful exits to acquirers such as Upsight and Oracle Financial Services.

He also serves as a director on the Board of Green Shield, a multi-billion dollar health benefits insurance and financial services company.

Mr. Wu will serve as an independent director of Antibe and is also a shareholder.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy